Bio
Dr. Iberri is a medical oncologist and hematologist who specializes in the treatment of hematologic malignancies. His clinical practices runs the gamut of malignant and non-malignant hematologic disorders including acute and chronic leukemias, multiple myeloma and lymphomas, and bleeding and thrombotic disorders. He is actively involved in clinical trials evaluating novel agents in hematologic malignancies. His research interests are in the development and application of biomarkers to select patients most likely to benefit from therapy.
Clinical Focus
- Lymphoma
- Chronic Lymphocytic Leukemia
- Multiple Myeloma
- Acute Myeloid Leukemia
- Chronic Myeloid Leukemia
- Polycythemia Vera
- Essential Thrombocythemia
- Myeloproliferative Disorders
- Iron Deficiency Anemia
- Venous Thromboembolism
- Aplastic Anemia
- Hematology
Administrative Appointments
-
Member, Stanford Professional Practice Evaluation Committee (2016 - Present)
Professional Education
-
Board Certification: American Board of Internal Medicine, Medical Oncology (2018)
-
Board Certification: American Board of Internal Medicine, Hematology (2016)
-
Fellowship: Stanford University School of Medicine (2015) CA
-
Board Certification: American Board of Internal Medicine, Internal Medicine (2013)
-
Residency: Stanford University School of Medicine (2013) CA
-
Internship: Stanford University School of Medicine (2011) CA
-
Medical Education: University of Vermont College of Medicine (2010) VT